Pfizer, Biontech submits data to authorise COVID-19 vaccine in children
Pfizer and BioNTech said Tuesday they have submitted Covid-19 vaccine data on children ages 5 to 11 to the US Food and Drug Administration for initial review, but are not yet seeking emergency use authorization.
READ ALSO: …